LIC MF Healthcare Fund
The fund maintains a concentrated bet on India's pharmaceutical and healthcare ecosystem, with nearly 70% in pharma companies and roughly 23% in hospital operators. The portfolio's stability month-on-month suggests the manager is confident in current valuations and competitive positions of large-cap drugmakers like Sun Pharma and mid-tier players such as Neuland. With over half the portfolio in just ten holdings and only modest cash, this is a high-conviction, low-diversification play suited for investors betting on domestic pharma's export strength and healthcare services growth.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| Direct Growth | ₹34.1593 | — | — | — | — |
| Regular Growth | ₹30.9613 | +9.70% | +10.71% | — | — |
| Direct IDCW | ₹34.1487 | — | — | — | — |
| Regular IDCW | ₹30.9618 | — | — | — | — |
Portfolio Metrics(latest month)
vs Category Peers
Highly DifferentiatedActive Share = ½Σ|wfund − wpeer|, computed using leave-one-out peer portfolio within SEBI category.
Similar Funds in Category
What Changed2026-03-31 → 2026-04-30
| Stock | Weight | |
|---|---|---|
| No new entries this month | ||
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Ltd. INE044A01036 | 11.22% |
| 2 | Apollo Hospitals Enterprise Ltd. INE437A01024 | 6.52% |
| 3 | Torrent Pharmaceuticals Ltd. INE685A01028 | 6.50% |
| 4 | Aurobindo Pharma Ltd. INE406A01037 | 5.15% |
| 5 | Divi's Laboratories Ltd. INE361B01024 | 4.74% |
| 6 | Fortis Healthcare Ltd. INE061F01013 | 4.70% |
| 7 | Neuland Laboratories Ltd. INE794A01010 | 4.59% |
| 8 | Onesource Specialty Pharma Ltd. INE013P01021 | 4.56% |
| 9 | Piramal Pharma Ltd. INE0DK501011 | 4.33% |
| 10 | Treps | 4.17% |
| 11 | Glenmark Pharmaceuticals Ltd. INE935A01035 | 3.41% |
| 12 | Navin Fluorine International Ltd. INE048G01026 | 3.32% |
| 13 | Alkem Laboratories Ltd. INE540L01014 | 3.20% |
| 14 | Cipla Ltd. INE059A01026 | 3.03% |
| 15 | IPCA Laboratories Ltd. INE571A01038 | 3.01% |
| 16 | Abbott India Ltd. INE358A01014 | 2.91% |
| 17 | Gland Pharma Ltd. INE068V01023 | 2.91% |
| 18 | Concord Biotech Ltd. INE338H01029 | 2.77% |
| 19 | Artemis Medicare Services Ltd. INE025R01021 | 2.70% |
| 20 | Metropolis Healthcare Ltd. INE112L01020 | 2.67% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.
Frequently Asked Questions
How many stocks does LIC MF Healthcare Fund hold?
LIC MF Healthcare Fund holds 26 stocks as per the latest AMFI portfolio disclosure. The top 5 positions account for 34.13% of NAV.
What is the largest holding in LIC MF Healthcare Fund?
The largest position in LIC MF Healthcare Fund is Sun Pharmaceutical Industries Ltd., accounting for 11.22% of NAV in the Pharmaceuticals & Biotechnology sector.
Is LIC MF Healthcare Fund a concentrated or diversified fund?
With a Gini coefficient of 0.265, LIC MF Healthcare Fund is well-diversified. The HHI concentration index is 46,062 bps, which is above the 2500 bps threshold for high concentration. The top 5 holdings together make up 34.13% of the portfolio.
What is the market cap allocation of LIC MF Healthcare Fund?
Based on SEBI's AMFI classification, LIC MF Healthcare Fund's equity portfolio is split as: Large Cap: 33.98%, Mid Cap: 28.92%, Small Cap: 33.23%. This reflects the fund's positioning within the market cap spectrum.
Which sectors does LIC MF Healthcare Fund invest in most?
LIC MF Healthcare Fund has the highest allocation to Pharmaceuticals & Biotechnology (68.82%), Healthcare Services (22.62%), Chemicals & Petrochemicals (4.69%). The fund is invested across 3 sectors in total.
How actively managed is LIC MF Healthcare Fund compared to other Sectoral / Thematic funds?
LIC MF Healthcare Fund has an Active Share of 89.92%, classifying it as "Highly Differentiated" among 237 Sectoral / Thematic peers. This means the fund takes significantly different stock positions compared to its category peers.